发明名称 SPIRO COMPOUNDS, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THE COMPOUNDS
摘要 Spiro compounds represented by the following general formula (I) or pharmaceutically acceptable acid-addition salts thereof: (I) wherein R1 and R2 are the same or different and each represents hydrogen, chlorine, etc.; n is 1, 2 or 3; a bond having a broken line represents a single or double bond; a nd A represents -X-(CH2)q-N(R3)(R4), a group represented by the following gener al formula (a), etc. (a) (wherein X represents oxygen or sulfur; q is 2 or 3; R 3 and R4 are the same or different and each represents C1-6 alkyl, etc., or R3 and R4 may form together with the adjacent nitrogen atom a piperidine ring, etc. optionally having one or two C1-6 alkyl substituents, etc.; R5 represen ts C1-6 alkyl, etc.; R6 represents hydrogen, etc.; and r and t independently represent each 1 or 2. These compounds are useful as selective estrogen receptor modulators having an effect of ameliorating symptoms of menopause. They are also expected as being usable as preventives and/or remedies for osteoporosis, symptoms of menopause and breast cancer.
申请公布号 CA2500869(A1) 申请公布日期 2004.04.15
申请号 CA20032500869 申请日期 2003.04.17
申请人 DAINIPPON PHARMACEUTICAL CO., LTD. 发明人 TSUJI, JUN-ICHI;MINATO, HISAO;IKENO, AKIHISA;KOHAYAKAWA, CHIE;NAKAGAWA, HIROSHI;WATANABE, NOBUHIDE
分类号 A61K31/40;A61K31/445;A61K31/4453;A61K31/451;A61K31/495;A61K31/55;A61P15/12;A61P19/10;A61P35/00;A61P43/00;C07C217/20;C07C217/24;C07D211/14;C07D295/092;(IPC1-7):C07C217/18;C07D295/088;C07D295/096;A61K31/138;C07D211/22 主分类号 A61K31/40
代理机构 代理人
主权项
地址